Research advances in the efficacy and safety of ofatumumab in patients with relapsing multiple sclerosis

ZHAO Yue, LI Lei

Journal of Apoplexy and Nervous Diseases ›› 2025, Vol. 42 ›› Issue (1) : 34-37.

PDF(892 KB)
PDF(892 KB)
Journal of Apoplexy and Nervous Diseases ›› 2025, Vol. 42 ›› Issue (1) : 34-37. DOI: 10.19845/j.cnki.zfysjjbzz.2025.0007
Rare Neurological Diseases Section

Research advances in the efficacy and safety of ofatumumab in patients with relapsing multiple sclerosis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 42(1): 34-37 https://doi.org/10.19845/j.cnki.zfysjjbzz.2025.0007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(892 KB)

Accesses

Citation

Detail
Sections
Recommended
Medical Publishing Centre of The First Hospital of Jilin University
Contact
Official website: www.zfysjjbzz.com
Official e-mail: zf_bjb@126.com
Official WeChat Platform: zfysjjbzz
Telephone number:(00)86-431-88782862/2863
Bank account information
Name: Jilin Dayijingcheng Media Co., Ltd.
Tax ID: 91220104MAC5259Q8T
Bank of deposit: Changchun Xi’an Road Sub-branch of China Construction Bank
Bank account: 22050145010009111679
Copyright © Editorial Office of Journal of Apoplexy and Nervous Diseases

/

〈 〉